Novo Nordisk A/S ADR buy Kepler Capital Markets
Start price
13.03.25
/
50%
€71.00
Target price
13.03.26
-
Performance (%)
-40.99%
Price
17:15
€40.80
Summary
This prediction is currently active. Massive losses of -40.99% have been the result for the BUY prediction by Kepler_Capital_Marke. Dividends of €1.10 are taken into consideration when calculating the performance. This prediction currently runs until 13.03.26. The prediction end date can be changed by Kepler_Capital_Marke at any time. Kepler_Capital_Marke has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -3.095% | -3.095% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Kepler_Capital_Marke for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Kepler Capital Markets from a "hold" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat